Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Second-line treatment with ramucirumab plus docetaxel extends survival in...
Dr Maurice Pérol - Centre Léon Bérard, Lyon, France
Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC ( Dr Maurice Pérol - Centre Léon Bérard, Lyon, France )
31 May 2014
Emerging pathways in immunotherapy
Prof Christopher Höller - Medical University of Vienna, Vienna, Austria
Emerging pathways in immunotherapy ( Prof Christopher Höller - Medical University of Vienna, Vienna, Austria )
20 May 2014
Checkpoint blockade: a concept or already a reality?
Prof Paolo Ascierto - National Cancer Institute 'Foundazione G. Pascale'...
Checkpoint blockade: a concept or already a reality? ( Prof Paolo Ascierto - National Cancer Institute 'Foundazione G. Pascale', Naples, Italy )
20 May 2014
Cancer evasion of the immune system: the fundamentals
Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland
Cancer evasion of the immune system: the fundamentals ( Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland )
20 May 2014
Upcoming trends in myeloma therapy
Dr Kenneth Anderson; Prof Gareth Morgan; Prof Paul Richardson
Upcoming trends in myeloma therapy ( Dr Kenneth Anderson; Prof Gareth Morgan; Prof Paul Richardson )
15 May 2014
Recent advances in mantle cell lymphoma: Expert panel discussion
Prof Simon Rule; Prof Umberto Vitolo; Prof Pier Luigi Zinzani; Prof Emanuele...
Recent advances in mantle cell lymphoma: Expert panel discussion ( Prof Simon Rule; Prof Umberto Vitolo; Prof Pier Luigi Zinzani; Prof Emanuele Zucci )
13 May 2014
Lecture: Current use of systemic therapies in localised disease
Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia
Lecture: Current use of systemic therapies in localised disease ( Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia )
12 May 2014
Lecture: Clinical Perspectives: How far are we from personalising treatment for...
Dr Paul de Souza - University of Western Sydney, New South Wales, Australia
Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients? ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )
12 May 2014
Lecture: Future strategies and targets for prostate cancer
Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany
Lecture: Future strategies and targets for prostate cancer ( Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany )
12 May 2014
Rituximab versus idelalisib in refractory CLL
Prof John Gribben - Queen Mary University London, London, UK; Prof Peter...
Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )
9 May 2014
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic...
Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014
WIN Symposium 2014: Breakthrough biomarker investigations and combination...
Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies ( Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg )
6 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation